Form D — Armis Biopharma, Inc.
0001604801-25-000003 · filed 2025-07-10
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $3,000,000
- Total sold
- $1,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Armis Biopharma, Inc.
- CIK
- 1604801
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2401 RESEARCH BLVD, SUITE 205
FORT COLLINS, CO 80526 - Phone
- 970-295-4373
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Theodore Ziemann · DirectorFort Collins, CO Find on LinkedIn ↗
-
Steve Coder · Executive OfficerFort Collins, CO Find on LinkedIn ↗
-
Alan Ruud · DirectorFort Collins, CO Find on LinkedIn ↗
-
Alan Smith, Ph.D. · DirectorFort Collins, CO Find on LinkedIn ↗
-
Christopher Rudd · DirectorFort Collins, CO Find on LinkedIn ↗
-
Michael Voss · Executive OfficerFort Collins, CO Find on LinkedIn ↗
-
Michael Litwack · DirectorFort Collins, CO Find on LinkedIn ↗
-
William Nelson, MD, Ph.D. · DirectorFort Collins, CO Find on LinkedIn ↗
View original on SEC EDGAR.